Therapeutic drug monitoring in breast cancer therapy – LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serum

Title:: Therapeutic drug monitoring in breast cancer therapy – LC-MS/MS method for quantification of the CDK4/6 inhibitors abemaciclib, palbociclib, ribociclib, and major metabolites abemaciclib M20 and M2 in human serum
Document type:: Zeitschriftenaufsatz
Author(s):: Habler, Katharina; Kalla, Anne-Sophie; Rychlik, Michael; Vogeser, Michael; Teupser, Daniel
Journal title:: Journal of Pharmaceutical and Biomedical Analysis
Year:: 2023
Journal volume:: 225
Pages contribution:: 115211
Fulltext / DOI:: doi:10.1016/j.jpba.2022.115211
Publisher:: Elsevier BV
E-ISSN:: 0731-7085
Date of publication:: 01.02.2023
BibTeX